Haemonetics Price Target Lowered to $41.00 at Benchmark Co. (HAE)

Haemonetics Price Target Lowered to $41.00 at Benchmark Co. (HAE)

The stock currently has a consensus rating of “Hold” and an average target price of $40.40. Haemonetics Corporation is a healthcare company engaged in providing blood management solutions to its cus…

7
Like
Save

Comments

Write a comment

*